Target intelligence / Profile preview

Hemagglutinin subunit HA2 (HA2) (HA2)

Target
HA2
Molecular classification
Viral surface glycoprotein, Class I viral fusion protein, Type I membrane protein
01

Overview

The Hemagglutinin subunit HA2 of the A/Indonesia/05/2005 (H5N1) influenza virus is a critical component of the viral envelope glycoprotein responsible for mediating host cell entry [UniProt Q207Z6]. While the HA1 subunit facilitates initial binding to sialic acid receptors, the HA2 subunit (the stalk or stem region) undergoes a dramatic pH-dependent conformational change within the endosome to trigger membrane fusion [Ekiert et al., 2009]. This fusion process allows the viral ribonucleoproteins to enter the host cytoplasm, initiating infection [Sui et al., 2009]. Because the HA2 stalk region is significantly more conserved across different influenza strains than the highly mutable HA1 head, it has become a primary target for the development of universal influenza vaccines and broadly neutralizing antibodies [Throsby et al., 2008]. Therapeutic agents targeting this region, such as monoclonal antibodies CR6261 or MEDI8852, typically function by stabilizing the pre-fusion conformation and preventing the structural rearrangements necessary for fusion [Dreyfus et al., 2012]. Targeting the HA2 stem is particularly vital for pandemic preparedness against highly pathogenic avian influenza strains like H5N1 [Lappala et al., 2018]. Small molecule inhibitors like Umifenovir also interact with the HA stem to block the fusion transition [Kadam & Wilson, 2017]. Research into this target focuses on overcoming the immunodominance of the HA1 head to elicit a robust protective response against the stalk [Impagliazzo et al., 2015].

Other names
HA2 stemHemagglutinin stalk regionHA2 fusion peptideInfluenza A virus H5N1 HA2H5N1 stalkA/Indonesia/05/2005 HA2
02

Mechanism of action

Stabilization of the pre-fusion conformation of hemagglutinin to prevent the pH-induced structural rearrangements required for membrane fusion and viral entry [Ekiert et al., 2009].

03

Biological functions

Membrane fusionViral entryEndosomal escapeConformational transition
04

Disease associations

InfectionInfluenzaAvian influenza
05

Safety considerations

Low immunogenicity of the stalk region compared to the immunodominant head [Impagliazzo et al., 2015]Potential for viral escape through mutations in the conserved stem [Dreyfus et al., 2012]Theoretical risk of antibody-dependent enhancement [Winarski et al., 2019]
06

Interacting drugs

CR6261

5 more in the full profile.

07

Biomarkers

Stalk-specific antibody titers [Impagliazzo et al., 2015]Microneutralization assay titers [Throsby et al., 2008]Viral RNA load [NCBI]

Beyond the preview

Go deeper on Hemagglutinin subunit HA2 (HA2) (HA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin subunit HA2 (HA2) (HA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call